Ratings by Guggenheim (Sandy Draper)
| Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 7/24/2024 | Medpace | MEDP | Maintain | Buy (N/A) |
|
Details | ||
| 2/15/2024 | IQVIA Holdings | IQV | Downgrade | Neutral (Buy) |
243.47 (174.49) |
-28.33% | Details | |
| 2/15/2024 | Charles River Labs | CRL | Downgrade | Neutral (Buy) |
245.12 (174.46) |
-28.83% | Details | |
| 8/9/2023 | Doximity Inc | DOCS | Downgrade | Neutral (Buy) |
32.79 (25.34) |
-22.72% | Details | |
| 6/26/2023 | Evolent Health | EVH | Maintain | Buy (N/A) |
|
Details | ||
| 5/8/2023 | Medpace | MEDP | Upgrade | Buy (Neutral) |
206.79 (470.59) |
127.57% | Details | |
| 3/20/2023 | The Oncology Insititute Inc. | TOI | Maintain | Buy (N/A) |
|
Details | ||
| 2/23/2023 | Charles River Labs | CRL | Upgrade | Buy (Neutral) |
219.09 (174.46) |
-20.37% | Details | |
| 2/14/2023 | Doximity Inc | DOCS | Maintain | Buy (N/A) |
|
Details | ||
| 10/27/2022 | IQVIA Holdings | IQV | Maintain | Buy (N/A) |
|
Details | ||
| 10/24/2022 | Teladoc | TDOC | Upgrade | Neutral (Sell) |
24.03 (5.08) |
-78.86% | Details | |
| 10/10/2022 | IQVIA Holdings | IQV | Maintain | Buy (N/A) |
|
Details | ||
| 10/10/2022 | ICON plc | ICLR | Maintain | Buy (N/A) |
|
Details | ||
| 9/14/2022 | Syneos | SYNH | Downgrade | Neutral (Buy) |
54.72 (42.98) |
-21.45% | Details | |
| 9/7/2022 | Signify Health Inc | SGFY | Downgrade | Neutral (Buy) |
29.10 (30.49) |
4.78% | Details | |
| 8/17/2022 | Teladoc | TDOC | Downgrade | Sell (Neutral) |
39.45 (5.08) |
-87.12% | Details | |
| 8/16/2022 | Signify Health Inc | SGFY | Maintain | Buy (N/A) |
|
Details | ||
| 8/1/2022 | ICON plc | ICLR | Maintain | Buy (N/A) |
|
Details | ||
| 7/18/2022 | GoodRx Holdings Inc. | GDRX | Maintain | Buy (N/A) |
|
Details | ||
| 6/22/2022 | Convey Holding | CNVY | Downgrade | Neutral (Buy) |
10.30 (10.51) |
2.04% | Details | |
| 5/24/2022 | Syneos | SYNH | New Coverage | Buy (N/A) |
70.91 (42.98) |
-39.39% | Details | |
| 5/24/2022 | Medpace | MEDP | New Coverage | Neutral (N/A) |
133.87 (470.59) |
251.53% | Details | |
| 5/24/2022 | ICON plc | ICLR | New Coverage | Buy (N/A) |
216.10 (107.20) |
-50.39% | Details | |
| 5/24/2022 | IQVIA Holdings | IQV | New Coverage | Buy (N/A) |
201.83 (174.49) |
-13.55% | Details | |
| 5/24/2022 | Charles River Labs | CRL | New Coverage | Neutral (N/A) |
232.64 (174.46) |
-25.01% | Details | |
| 5/18/2022 | Doximity Inc | DOCS | Maintain | Buy (N/A) |
|
Details | ||
| 5/9/2022 | agilon health Inc | AGL | Maintain | Buy (N/A) |
|
Details | ||
| 5/9/2022 | Signify Health Inc | SGFY | Maintain | Buy (N/A) |
|
Details | ||
| 4/28/2022 | Teladoc | TDOC | Downgrade | Neutral (Buy) |
55.99 (5.08) |
-90.93% | Details | |
| 4/7/2022 | Convey Holding | CNVY | New Coverage | Buy (N/A) |
6.47 (10.51) |
62.44% | Details | |
| 4/7/2022 | GoodRx Holdings Inc. | GDRX | New Coverage | Buy (N/A) |
19.28 (2.28) |
-88.17% | Details | |
| 4/7/2022 | Doximity Inc | DOCS | New Coverage | Buy (N/A) |
53.23 (25.34) |
-52.4% | Details | |
| 4/7/2022 | Accolade Inc. | ACCD | New Coverage | Neutral (N/A) |
17.72 (7.02) |
-60.38% | Details | |
| 4/7/2022 | HealthEquity, Inc | HQY | New Coverage | Buy (N/A) |
67.21 (78.36) |
16.59% | Details | |
| 4/7/2022 | Teladoc | TDOC | New Coverage | Buy (N/A) |
71.22 (5.08) |
-92.87% | Details | |
| 3/30/2022 | 1Life Healthcare Inc. | ONEM | New Coverage | Neutral (N/A) |
10.46 (16.47) |
57.46% | Details | |
| 3/30/2022 | Signify Health Inc | SGFY | New Coverage | Buy (N/A) |
17.68 (30.49) |
72.45% | Details | |
| 3/30/2022 | Privia Health Group Inc | PRVA | New Coverage | Buy (N/A) |
25.13 (23.27) |
-7.4% | Details | |
| 3/30/2022 | Oak Street Health | OSH | New Coverage | Neutral (N/A) |
27.05 (39.00) |
44.18% | Details | |
| 3/30/2022 | Evolent Health | EVH | New Coverage | Buy (N/A) |
31.18 (3.17) |
-89.83% | Details | |
| 3/30/2022 | agilon health Inc | AGL | New Coverage | Buy (N/A) |
24.07 (0.60) |
-97.51% | Details |
